Levothyroxine Sodium Tablets recall — ACCORD HEALTHCARE, INC.
Subpotent Drug
Company / brand: ACCORD HEALTHCARE
Affected product: Levothyroxine Sodium Tablets
Official ID D-0656-2026 · Official record ↗
Notice names this product. ACCORD HEALTHCARE’s Levothyroxine Sodium Tablets is named in FDA Class II recall D-0656-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Subpotent Drug Identifying details: Lot # D2401522, Exp Date: 06/2026.. Units affected: 6432 bottles. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Subpotent Drug
Company / brand: ACCORD HEALTHCARE
Affected product: Levothyroxine Sodium Tablets
Official ID D-0656-2026 · Official record ↗
See all ACCORD HEALTHCARE recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.